Hereditary Hemorrhagic Telangiectasia (HHT) affects around 1 in 5,000 people worldwide, yet it remains widely underdiagnosed. Early diagnosis is key to improving outcomes and quality of life for people living with HHT. 🎥 Watch the e-learning module w/ Raj Kasthuri: academy.eahad.org/eahad/2026/e...
EAHAD - European Association for Haemophilia and Allied Disorder
